

Why Human Oversight and Management Will Still Matter in AI-Driven Pharma Operations - with Yunke Xiang of Sanofi
12 snips Sep 9, 2025
Yunke Xiang, the Global Head of Data Science for Manufacturing, Supply Chain, and Quality at Sanofi, discusses the transformative power of AI in pharmaceutical operations. He highlights how generative AI is improving data access and automating regulatory tasks. Yunke emphasizes the crucial need for human oversight as AI moves from simple tools to more autonomous agents. He also explores the evolving role of management in guiding teams that include both humans and AI, navigating the complexities of this new landscape.
AI Snips
Chapters
Transcript
Episode notes
Talk To Your Data Unlocks Ops Visibility
- Generative AI makes operational data accessible via natural-language queries across systems like MES and deviation logs.
- This shifts reporting from SQL-dependent analysts to domain leaders who can get answers instantly.
AI Streamlines Content And Regulatory Drafting
- Generative AI drafts and summarizes content such as reports and regulatory submissions to reduce repetitive work.
- This increases consistency and frees experts for higher-value review and decisions.
Deploy Copilots For Faster Onboarding
- Use co-pilot assistants to accelerate onboarding and provide on-demand answers to SOP and escalation questions.
- Deploy them to reduce floor errors and speed knowledge transfer for new operators.